14 research outputs found

    The effects of parental loss in childhood on mental health in adults

    Get PDF
    ๋ณด๊ฑด๋Œ€ํ•™์›/๋ฐ•์‚ฌBackground Previous research has focused on the mental health of children and adolescents who experienced parental loss. Studies so far have been investigating the short-term effects of loss rather than the long-term effects. Parental death in childhood has little identified yet as a risk factor for mental health problems in adulthood. Objectives: The purpose of this study was to investigate the effects of parental loss in childhood as a risk factor for mental health problems, such as depression symptoms and suicidal ideation, in adults in the Republic of Korea. Methods This study used the Korean Welfare Panel Study (KOWEPS) data from 2006 to 2013 with follow-up examinations each year. Information on childhood (0-17 years of age) parental loss was collected retrospectively in 2006. Prevalence of depression symptoms was measured by the Korean version of the Center for Epidemiologic Studies Depression Scale (CES-D) each year. A cut-off of 16 points or more was used to define depression symptoms. After excluding missing values, the study subjects for depression symptom analyses included 13,671 (84,012 observations). In the suicidal ideation analyses, (9,285 subjects (26,986 observations) from 2011 to 2013 were included. A Generalized Estimating Equations (GEE) analysis was conducted to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) of depression symptoms and suicidal ideation respectively in relation to parental loss in childhood. Results Among the study population (n=13,671), 26.2% (n=3,577) were suffering from depression symptoms, and 18.7% (n=2,566) had experienced parental loss in childhood. Parental loss was associated with depression symptoms (OR = 1.185; 95% CI: 1.114-1.260). After stratification by gender, the risk of depression symptoms was significant for both men and women who had experienced parental loss (OR = 1.189; 95% CI: 1.076-1.314 in men; OR = 1.174; 95% CI: 1.086-1.268 in women). ORs by age group indicated that middle-aged (OR = 1.229; 95% CI: 1.115-1.354) and elderly (OR = 1.184; 95% CI: 1.089-1.287) participants were significantly more likely to exhibit depression symptoms. Among the total population of 9,285, the number of people who experienced suicidal ideation was 12.8% (n=1,192). The number of people who experienced parental loss was 19.5% (n=1,814). Parental loss was associated with suicidal ideation (OR = 1.189; 95% CI: 1.041-1.358). After stratifying by gender, the risk of suicidal ideation was not significant for men or women who had experienced parental loss (OR = 1.194; 95% CI: 0.955-1.494 in men; OR = 1.163; 95% CI: 0.985-1.373 in women). ORs by age group indicated that middle-aged participants were at a significantly higher risk of suicidal ideation (OR = 1.260; 95% CI: 1.031-1.540). However, young adults and the elderly were not. Conclusions Parental death in childhood was positively associated with the risk of adulthood depression symptoms and suicidal ideation respectively. The risk of depression symptoms was statistically significant for both men and women. The risk was significantly higher in middle-aged and elderly people. The risk of suicidal ideation was significant for middle-aged people. Therefore, this study identified that parental death in childhood negatively affected mental health in adults. In this regard, the results of this study will help policy development of family support programs for bereaved families.ope

    A single measure of cancer burden combining incidence with mortality rates for worldwide application.

    Get PDF
    We attempted to develop an indicator combining incidence with mortality rates (single measure of cancer burden, SMCB) and to compare the magnitudes of cancer burden by world region. The SMCB was used to measure the size of cancer burden summarizing the incidence and mortality. The incidence and mortality were divided in equivalent forms and were split. The criteria dividing the size of cancer burden were used as the maximum incidence and mortality by men and women according to the world database, and the value corresponding to 10% of each maximum was set as the cut-off value. In SMCB, the size of cancer burden was highest for men with lung cancer (SMCB=18) and for women with breast cancer (SMCB=14) in MDR (more developed regions) compared to the size of burden in LDR (lower developed regions) (lung, SMCB=11, breast, SMCB=8). For men, the size of cancer burden by region was highest in EURO (SMCB=18, lung), followed by WPRO (SMCB=16, lung), PAHO (SMCB=14, prostate), AFRO (SMCB=8, prostate) and SEARO (SMCB=7, lung). Moreover, for women, the size of cancer burden was greatest in EURO (SMCB=14, breast), followed by PAHO (SMCB=13, breast), AFRO (SMCB=11, cervix uteri), EMRO (SMCB=9, breast) or SEARO (SMCB=8, cervix uteri) and WPRO (SMCB=7, lung). The summary indicator will help to provide a priority setting for reducing cancer burden in health policy.ope

    ์‚ฌ๋žŒ ์ค‘์ด์ ๋ง‰์„ธํฌ ๋‚ด์—์„œ Interleukin 1-beta์— ์˜ํ•œ Na+-K+-2Cl- cotransporter์˜ ์ฆ๊ฐ€ ์—ฐ๊ตฌ

    No full text
    Dept. of Medical School/์„์‚ฌ[ํ•œ๊ธ€]์‚ผ์ถœ์„ฑ์ค‘์ด์—ผ์€ ๊ฐ๊ธฐ๋‚˜ ๋น„์—ผ, ๊ธ‰์„ฑ์ค‘์ด์—ผ ๋“ฑ์ด ์ƒ๊ธด ํ›„์— ์ ์ ˆํ•œ ์น˜๋ฃŒ๊ฐ€ ๋˜์ง€ ์•Š์•„ ๋งŒ์„ฑ๋ฐœ์—ด์ด๋‚˜ ํ†ต์ฆ ๋“ฑ ์—ผ์ฆ์˜ ์ฆ์ƒ์ด ์—†์ด ๊ณ ๋ง‰ ์•ˆ์— ์‚ผ์ถœ์•ก์ด ์ฐจ ์žˆ๋Š” ๊ฒฝ์šฐ๋กœ ์†Œ์•„์˜ ๊ฐ€์žฅ ํ”ํ•œ ์ฒญ๋ ฅ์žฅ์• ์˜ ์›์ธ์ด ๋˜๊ณ  ์žˆ๋‹ค. ์‚ผ์ถœ์•ก์˜ ๋ฐœ์ƒ์„ ๊ทธ ์„ฑ๋ถ„ ์ค‘์— ๊ฐ€์žฅ ๋งŽ์€ ์—ผ์ฆ์„ฑ cytokine ์œผ๋กœ ์•Œ๋ ค์ ธ interleukin-1ss(IL-1ss)๊ฐ€ ์‚ผ์ถœ์„ฑ ์ค‘์ด์—ผ ํ™˜์ž์˜ ์ค‘์ด๊ฐ• ๋‚ด์—์„œ ์ฃผ๋ณ€ ์„ธํฌ์— ์ฒด์ ๊ณผ ๋ถ„๋น„, ๋ฌผ ์ˆ˜์†ก์— ๊ด€์—ฌํ•˜๋Š” ๊ธฐ๋Šฅ์„ฑ ๋ง‰ ๋‹จ๋ฐฑ์งˆ์— ๋ฏธ์น˜๋Š” ์–ด๋–ค ์˜ํ–ฅ์œผ๋กœ ์˜ˆ์ƒํ–ˆ๋‹ค.์ข…๋ž˜์˜ ์—ฐ๊ตฌ์—์„œ IL-1ss์˜ ์„ธํฌ์ƒ๋ฆฌํ•™์ ์ธ ๊ธฐ๋Šฅ์€ ์•„์ง ์—ฐ๊ตฌ๊ฐ€ ๋ฏธ๋น„ํ•œ ์‹ค์ •์ด๋‹ค. ๊ทธ๋ž˜์„œ ๊ธฐ๋„์ ์•ก์—์„œ ์„ธํฌ ์ฒด์ ๊ณผ ๋ถ„๋น„๊ธฐ๋Šฅ์ด ์žˆ๋Š” Na+-K+-Cl- cotransporter 1(NKCC1)์ด ์กฐ์ง ํŠน์ด์„ฑ์ด ๋น„์Šทํ•œ ์ค‘์ด์ ๋ง‰์ƒํ”ผ์„ธํฌ์—์„œ ๋ฐœํ˜„ํ•˜๋Š”์ง€์˜ ์—ฌ๋ถ€์™€ IL-1ss์—๊ฒŒ์„œ ๋ฐ›๋Š” ์˜ํ–ฅ์„ ๋ถ„์„ํ•˜์˜€๋‹ค.์ •์ƒ์ธ์˜ ์ค‘์ด์ ๋ง‰์ƒํ”ผ์„ธํฌ๋ฅผ ์ฑ„์ทจํ•˜์—ฌ P2 ๋‹จ๊ณ„๊นŒ์ง€ ๋ฐฐ์–‘ํ•œ ํ›„ H+๋ฅผ ์„ธํฌ๋ง‰์˜ ์•ˆํŒŽ์œผ๋กœ ๊ฐ•์ œ ์ด๋™์‹œํ‚ค๋ฉฐ pH ๋ณ€ํ™”๋ฅผ ํ†ตํ•ด ์„ธํฌ์˜ ๊ธฐ์ €์™ธ์ธก๋ง‰์—์„œ NKCC1์˜ ์‹ค์ง์ ์ธ ๊ธฐ๋Šฅ์„ ํ™•์ธํ•˜๋ฉด์„œ ๋™์‹œ์— IL-1ss๋ฅผ ์ฒ˜๋ฆฌํ•˜์˜€์„ ๋•Œ ๊ทธ ๊ธฐ๋Šฅ์ด ์œ ์˜์„ฑ ์žˆ๊ฒŒ ์ฆ๊ฐ€ํ•˜๋Š” ๊ฒƒ์„ ํ™•์ธํ•˜์˜€๋‹ค.๋˜ํ•œ ๋‹จ๋ฐฑ์งˆ ์ˆ˜์ค€์—์„œ IL-1ss๋ฅผ ์‹œ๊ฐ„ ๋ณ„๋กœ ์ฒ˜๋ฆฌํ•œ ์‹œ๋ฃŒ์™€ ์‚ผ์ถœ์„ฑ ์ค‘์ด์—ผ ํ™˜์ž๊ตฐ์—์„œ ์ฑ„์ทจํ•œ ์‹œ๋ฃŒ๊ฐ€ ๋™์ผํ•œ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์˜€์œผ๋ฉฐ NKCC1์„ ํŠน์ด์ ์œผ๋กœ ์ €ํ•ดํ•˜๋Š”, bumetanide ๋ฅผ ์ฒ˜๋ฆฌํ•˜์—ฌ ์‹ค์งˆ์ ์œผ๋กœ ๋ฌผ ์ˆ˜์†ก ์–‘์ด ์ค„์–ด๋“œ๋Š” ๊ฒฐ๊ณผ๋กœ ๋ณด์•„ NKCC1์ด ๊ธฐ๋„์ƒํ”ผ์„ธํฌ์™€ ๋งˆ์ฐฌ๊ฐ€์ง€๋กœ ์ •์ƒ์‚ฌ๋žŒ ์ค‘์ด ์ ๋ง‰์ƒํ”ผ์„ธํฌ์—์„œ๋„ ๊ทธ ๊ธฐ์กด์˜ ์—ญํ• ์„ ํ•˜๋Š” ๊ฒƒ์œผ๋กœ ๋ณด์—ฌ์ง„๋‹ค. ์„ธํฌ ์ฒจ๋ถ€์ธก์— ์ผ์ •๋Ÿ‰์˜ Krebโ€™s solution ์„ ๋„ฃ์–ด์ฃผ๊ณ  IL-1ss๋ฅผ ์ฒ˜๋ฆฌํ–ˆ์„ ๋•Œ ๋ฌผ์˜ ๋ถ„๋น„๋Ÿ‰์ด ๋Œ€์กฐ๊ตฐ์— ๋น„ํ•ด ์œ ์˜์„ฑ ์žˆ๊ฒŒ ์ฆ๊ฐ€ํ•˜์˜€์œผ๋ฉฐ ์ด๋ฅผ ์ค‘์ด ๋‚ด ์‚ผ์ถœ์•ก์˜ ๋ฐœ์ƒ์›์ธ์œผ๋กœ ์ถ”์ •ํ•œ๋‹ค.์ด์™€ ๊ฐ™์€ ์—ฐ๊ตฌ๋“ค์ด ์—ผ์ฆ์„ฑ cytokine ์— ์˜ํ•œ ๊ธฐ๋Šฅ์„ฑ ๋ง‰ ๋‹จ๋ฐฑ์งˆ์˜ ์ด์ƒ์œผ๋กœ ์•ผ๊ธฐ๋˜๋Š” ์‚ผ์ถœ์„ฑ ์ค‘์ด์—ผ์˜ ๋ณ‘๋ฆฌ ์ƒ๋ฆฌ๋ฅผ ์—ฐ๊ตฌํ•˜๋Š”๋ฐ ๊ธฐ์ดˆ๊ฐ€ ๋  ๊ฒƒ์ด๋‹ค. [์˜๋ฌธ]Disruption of periciliary fluid homeostasis is the main pathogenesis of otitis media with effusion (OME), which is one of the most common childhood diseases. Although the underlying molecular mechanisms are unclear, it has been suggested that the altered functions of ion channels and transporters are involved in the fluid collection of middle ear cavity of OME patients. In the present study, we analyzed effects of the inflammatory cytokine Interleukin-1ss(IL-1ss) on Na+-K+-2Cl-- cotransporter 1 (NKCC1) in human middle ear cells. Intracellular pH (pHi) were measured in primary cultures of normal human middle ear epithelial (NHMEE) cells using a double perfusion chamber, which enabled us to analyze membrane-specific transporter activities. NKCC activities were estimated by the pHi reduction due to bumetanide-sensitive intracellular uptake of NH4+. In addition, transepithelial fluid transport was measured with or without bumetanide-treatments. NKCC activities were observed in the basolateral membrane, but not in the luminal membrane of NHMEE cells. Correspondingly, immunoblotting of membrane-cultured NHMEE cells revealed the expression of NKCC1 on the basolateral membrane. Interestingly, IL-1ss treatments augmented the basolateral NKCC activities and increased NKCC1 expression. In addition, IL-1ss stimulated bumetanide-sensitive fluid transport in NHMEE cells. Furthermore, NKCC1 expression was increased in middle ear cells from the patients with OME when compared to samples from control individuals. The above results provide comprehensive evidence that the inflammatory cytokine IL-1ฮฒ upregulates NKCC1 in the middle ear epithelial cells, which would be one of the important underlying mechanisms of fluid overcollection in patients with OME.ope

    ์‚ฌํšŒ์„ฑ ์ฆ์ง„ ํ”„๋กœ๊ทธ๋žจ์ด ์ •์‹ ๊ณผ ๋ณ‘๋™์— ์ž…์›ํ•œ ์†Œ์•„ยท์ฒญ์†Œ๋…„์˜ ๋˜๋ž˜๊ด€๊ณ„, ์†Œ์™ธ๊ฐ์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ฐ„ํ˜ธํ•™๊ณผ ๊ฐ„ํ˜ธํ•™์ „๊ณต,2000.Maste

    P2Y2 agonist induces mucin secretion via Ca2+- and inositol 1,4,5-triphosphate-dependent pathway in human middle ear epithelial cells

    No full text
    Purinergic agonists regulate mucin secretion in the airway epithelial cells. This study examined the effects of the apical application of purinergic agonists on Ca(2+) influx ([Ca(2+)](i)), and mucin secretion along with their underlying signaling pathway in normal human middle ear epithelial (NHMEE) cells. The apical membrane of NHMEE cells were stimulated with various purinergic agonists, including UTP, and the [Ca(2+)](i) was measured using a miniature Ussing double perfusion chamber. P2Y(2) receptor in NHMEE cells was also localized by immunohistochemistry. UTP-induced mucin secretion was quantified by an immunoblotting assay. The order of the purinergic agonist potency with respect to [Ca(2+)](i) determined in this study was ATP = UTP > 2-MeSATP > UDP >> adenosine which is consistent with that obtained from P2Y(2) receptor activation. The P2Y(2) receptor is expressed in the apical membrane of monolayered cultured NHMEE cells. Apical UTP-induced [Ca(2+)](i) was inhibited by 2-aminoethoxydiphenyl borate (2-APB) but not by ryanodine. UTP-induced mucin secretion was inhibited by a Ca(2+) chelating agent, BAPTA-AM, and was stimulated by ionomycin. UTP-induced mucin secretion was also suppressed by U73122 and 2-APB, while Calphostin C suppressed it to a small extent and PD98059 was ineffective. Caffeine also inhibited the UTP-induced [Ca(2+)](i) and mucin secretion. These results suggest that the P2Y(2) receptor is expressed in NHMEE cells, and plays a major role in modulating the [Ca(2+)](i) from the IP(3)-sensitive intracellular Ca(2+) store. UTP-induced mucin secretion in NHMEE cells is strongly dependent on Ca(2+)- and IP(3).restrictio

    Clinical study on metabolic liver diseases in infancy and childhood

    No full text
    ์˜ํ•™๊ณผ/์„์‚ฌ[ํ•œ๊ธ€] ๊ฐ„์žฅ์€ ์ฒด๋‚ด ํƒ„์ˆ˜ํ™”๋ฌผ, ์ง€์งˆ, ๋‹จ๋ฐฑ, ๋ฌด๊ธฐ์งˆ ๋ฐ ๋น„ํƒ€๋ฏผ ๋“ฑ์˜ ํ•ฉ์„ฑ, ๋ถ„ํ•ด, ์กฐ์ ˆ ๋“ฑ์˜ ๋Œ€์‚ฌ๊ณผ์ •์— ์ค‘์ถ”์ ์ธ ์—ญํ• ์„ ํ•˜๋Š” ์žฅ๊ธฐ๋กœ, ํšจ์†Œ๊ฒฐํ• ํ˜น์€ ๋Œ€์‚ฌ์ด์ƒ์œผ๋กœ ์ธํ•˜์—ฌ ๊ฐ„์žฅ์— ์˜ํ–ฅ์„ ์ค„ ๋•Œ ์„ ์ฒœ์„ฑ ๋Œ€์‚ฌ์งˆํ™˜๋“ค์ด ๋ฐœ์ƒ๋  ์ˆ˜ ์žˆ๋‹ค. ์ด๋Ÿฌํ•œ ์งˆํ™˜๋“ค์˜ ์ž„์ƒ์–‘์ƒ์€ ๊ฐ์—ผ์„ฑ, ์ค‘๋…์„ฑ ํ˜น์€ ๋‹ค๋ฅธ ์ „์‹ ์งˆํ™˜ ๋“ฑ์˜ ๋‹ค์–‘ํ•œ ์ž„์ƒ์†Œ๊ฒฌ๊ณผ ๋งค์šฐ ์œ ์‚ฌํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์–ด ์ง„๋‹จ์‹œ ์ฃผ์˜๋ฅผ ์š”ํ•˜๋ฉฐ, ๊ทธ ๋ณ‘๋ฆฌ๊ธฐ์ „์˜ ์ •ํ™•ํ•œ ์ดํ•ด์™€ ์กฐ๊ธฐ์ง„๋‹จ์ด ์•ž์œผ๋กœ ์น˜๋ฃŒ ๋ฐ ์˜ˆํ›„์— ๊ฒฐ์ •์ ์ธ ์—ญํ• ์„ ํ•  ์ˆ˜ ์žˆ๋‹ค. ํ•œํŽธ ์šฐ๋ฆฌ๋‚˜๋ผ์—์„œ๋Š” ์ƒ๋Œ€์ ์œผ๋กœ ์ ์€ ํ™˜์•„์˜ ์ˆ˜์™€ ๋”๋ถˆ์–ด ์ด ๋ณ‘์— ๋Œ€ํ•œ ๊ด€์‹ฌ์ด ์ ๊ณ  ํ™•์ง„๋ฐฉ๋ฒ•์˜ ๋ฌธ์ œ์  ๋“ฑ์œผ๋กœ ๋‹ค๋ฅธ ๋ถ„์•ผ๋ณด๋‹ค ๋‚™ํ›„๋œ ์ƒํƒœ์— ์žˆ์œผ๋ฉฐ ์ด๋Ÿฌํ•œ ์„ ์ฒœ์„ฑ ๋Œ€์‚ฌ์„ฑ ๊ฐ„์งˆํ™˜์— ๋Œ€ํ•œ ๋ฌธํ—Œ์„ ์ฐพ์•„๋ณด๊ธฐ ํž˜๋“  ์‹ค์ •์— ์žˆ๋‹ค. ์ด์— ์ €์ž๋Š” 1980๋…„ 1์›”๋ถ€ํ„ฐ 1990๋…„ 12์›”๊นŒ์ง€ ๋งŒ 11๋…„๋™์•ˆ ์—ฐ์„ธ์˜๋Œ€ ์„ธ๋ธŒ๋ž€์Šค๋ณ‘์› ์†Œ์•„๊ณผ์— ๋‚ด์›ํ•˜์˜€๋˜ ์„ ์ฒœ์„ฑ ๋Œ€์‚ฌ์งˆํ™˜ ํ™˜์•„๋“ค์ค‘ ๊ฐ„์žฅ์— ์ด์ƒ ์†Œ๊ฒฌ์„ ๋ณด์˜€๋˜ ํ™˜์•„๋“ค์„ ๋Œ€์ƒ์œผ๋กœ ์›์ธ์งˆํ™˜๋ณ„ ๋ถ„ํฌ์ƒํƒœ, ์ž„์ƒ์†Œ๊ฒฌ, ๊ฒ€์‚ฌ์†Œ๊ฒฌ ๋ฐ ๋ณ‘๋ฆฌํ•™์  ์†Œ๊ฒฌ ๋“ฑ์„ ์•Œ์•„๋ณด๊ณ ์ž ๋ณธ ์—ฐ๊ตฌ๋ฅผ ์‹œํ–‰ํ•˜์—ฌ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์–ป์—ˆ๋‹ค. 1. ์„ ์ฒœ์„ฑ ๋Œ€์‚ฌ์งˆํ™˜ ํ™˜์•„ 62๋ก€ ์ค‘ 30๋ก€(48%)์—์„œ ๊ฐ„์žฅ์— ์ด์ƒ์†Œ๊ฒฌ์ด ์žˆ์—ˆ์œผ๋ฉฐ, ๊ทธ ์›์ธ์งˆํ™˜์œผ๋กœ๋Š” ๋‹น์›๋ณ‘ 11๋ก€, ์œŒ์Šจ๋ณ‘ 9๋ก€, ๊ณ ์„ธ๋ณ‘ 4๋ก€, phenylketonuria 2๋ก€, mucopolysaccharidosis 2๋ก€, hereditary tyrosinemia 1๋ก€, histidinemia 1๋ก€ ๋“ฑ์ด ์žˆ์—ˆ๋‹ค. 2. ์ „์ฒด์ ์œผ๋กœ ๋ณผ ๋•Œ ์—ฐ๋ น ๋ฐ ์„ฑ๋ณ„ ๋ถ„ํฌ๋Š”, 1-5์„ธ ์‚ฌ์ด์˜ ์—ฐ๋ น๊ตฐ์ด ์ „์ฒด์˜ 43%๋กœ ๊ฐ€์žฅ ๋งŽ์•˜๊ณ , ๋‚จ๋…€์˜ ๋น„๋Š” 1:1.1๋กœ ๊ฑฐ์˜ ๋น„์Šทํ•˜์˜€๋‹ค. ๋Œ€์‚ฌ์„ฑ๊ฐ„์งˆํ™˜์˜ ์„ฑ๋ณ„ ๋ถ„ํฌ๋Š” ๋‹น์›๋ณ‘๊ณผ ์œŒ์Šจ๋ณ‘์€ ๋‚จ๋…€ ๋น„๊ฐ€ ๊ฐ๊ฐ 5:6 ๋ฐ 5:4๋กœ ๋น„์Šทํ•˜์˜€์œผ๋‚˜ ๊ณ ์„ธ๋ณ‘์€ 1:3์œผ๋กœ ์—ฌ์•„์— ํ˜ธ๋ฐœํ•˜์˜€๋‹ค. 3. ์ง„๋‹จ์‹œ ์—ฐ๋ น์€ ์œŒ์Šจ๋ณ‘์ด 11.3์„ธ๋กœ ๊ฐ€์žฅ ๋†’์•˜๊ณ  ๋‹น์›๋ณ‘์œผ๋กœ 4.9์„ธ, phenylketonuria 4.0์„ธ ์ˆœ์ด์—ˆ์œผ๋ฉฐ, ์ง„๋‹จ์‹œ๊นŒ์ง€ ์ฆ์ƒ์ด ์ง€์†๋˜์—ˆ๋˜ ๊ธฐ๊ฐ„์€ phenylketonuria๊ฐ€ 48.5๊ฐœ์›”๋กœ ๊ฐ€์žฅ ๊ธธ์—ˆ๊ณ  ๋‹น์›๋ณ‘์ด 29.1๊ฐœ์›” ๋“ฑ์˜ ์ˆœ์ด์—ˆ๋‹ค. 4. ์žฌํƒœ๊ธฐ๊ฐ„, ์ถœ์ƒ์‹œ ์ฒด์ค‘ ๋ฐ ์ž…์›๋‹น์‹œ ์„ฑ์žฅ์ƒํƒœ๋Š” 90%์˜ ํ™˜์•„๊ฐ€ ์žฌํƒœ์—ฐ๋ น์ด 37์ฃผ ์ด์ƒ์ด์—ˆ๊ณ  6.7%์˜ ํ™˜์•„๋งŒ์ด ์ถœ์ƒ์‹œ ์ฒด์ค‘์ด 2.5kg๋ฏธ๋งŒ์˜ ์ €์ฒด์ค‘์•„์˜€์œผ๋‚˜, ์—ฐ๋ น์ด ์ฆ๊ฐ€ํ•˜๋ฉด์„œ ํ•ด๋‹น์—ฐ๋ น์— ๋Œ€ํ•œ ์ฒด์ค‘ ๋ฐ ์‹ ์žฅ์œผ๋กœ ํ‰๊ฐ€ํ•œ ์„ฑ์žฅ์ƒํƒœ๊ฐ€ 50 ๋ฐฑ๋ถ„์œ„์ˆ˜ (percentile) ๋ฏธ๋งŒ์ธ ํ™˜์•„๊ฐ€ ๊ฐ๊ฐ 30๋ก€์ค‘ 21๋ก€(70%) ๋ฐ 16๋ก€์ค‘ 9๋ก€(56%)์ธ ๊ฒƒ์œผ๋กœ ๋ณด์•„ ์ ์ฐจ ์„ฑ์žฅ์žฅ์• ๊ฐ€ ์˜จ๋‹ค๋Š” ์ ์„ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. 5. ์ž„์ƒ์†Œ๊ฒฌ์œผ๋กœ๋Š” ๊ฐ„์žฅ์ข…๋Œ€(53%), ๋น„์žฅ์ข…๋Œ€(43%), ๊ฐ„๋น„์žฅ์ข…๋Œ€(40%), ๋ณต๋ถ€ํŒฝ๋งŒ(40%), ์„ฑ์žฅ์žฅ์• (30%) ๋“ฑ์˜ ์ˆœ์œผ๋กœ ๋งŽ์•˜์œผ๋ฉฐ, ์งˆํ™˜๋ณ„ ๊ฐ„๋น„์žฅ์ข…๋Œ€์˜ ์†Œ๊ฒฌ์œผ๋กœ, ๋‹น์›๋ณ‘์—์„œ๋Š” ๊ฐ„์žฅ์ข…๋Œ€๊ฐ€, ๊ณ ์„ธ๋ณ‘์—์„œ๋Š” ๋น„์žฅ์ข…๋Œ€์˜ ์†Œ๊ฒฌ์ด ์‹ฌํ•จ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. 6. ์ด 30๋ก€์ค‘ 14๋ก€(47%)์—์„œ ๊ฐ€์กฑ๋ ฅ์ด ์žˆ์—ˆ์œผ๋ฉฐ, ๊ทธ์ค‘ ํ˜•์ œ๊ฐ€ 9๋ก€(30%)๋กœ ๊ฐ€์žฅ ๋งŽ์•˜๋‹ค. 7. ๊ฒ€์‚ฌ์†Œ๊ฒฌ์œผ๋กœ๋Š” ์ด30๋ก€์ค‘, ์ „๋ก€์—์„œ AST์˜ ์ƒ์Šน, 18๋ก€(60%)์—์„œ ALT์˜ ์ƒ์Šน, 15๋ก€(50%)์—์„œ ๋นˆํ˜ˆ ๋ฐ 11๋ก€(37%)์—์„œ ํ˜ˆ์ฒญ bilirubin ๋†๋„์˜ ์ƒ์Šน์†Œ๊ฒฌ๋“ฑ์„ ๋ณผ ์ˆ˜ ์žˆ์—ˆ๋‹ค. 8. ๋ณ‘๋ฆฌ์†Œ๊ฒฌ์œผ๋กœ๋Š” ์ฃผ๋กœ ๋‹น์›๋ณ‘์—์„œ ๊ฐ„์žฅ์„ธํฌ์˜ ํŒฝ์œค, ๋‹น์›ํ•ต, ๊ฐ„๋‚ด๋‹ด์ฆ™์ •์ฒด, ์ง€๋ฐฉํ™” ๋“ฑ์˜ ์†Œ๊ฒฌ์„ ๋ณผ ์ˆ˜ ์žˆ์—ˆ๊ณ , ์œŒ์Šจ๋ณ‘์—์„œ๋Š” ๊ฐ„๊ฒฝ๋ณ€์ด, ๊ณ ์„ธ๋ณ‘์—์„œ๋Š” ๊ณ ์„ธ์„ธํฌ ๋“ฑ์ด ์ฃผ ์†Œ๊ฒฌ์ด์—ˆ๋‹ค. ๊ฒฐ๋ก ์ ์œผ๋กœ ์†Œ์•„๊ธฐ ์„ ์ฒœ์„ฑ ๋Œ€์‚ฌ์งˆํ™˜ ํ™˜์•„์˜ ์•ฝ 50%์—์„œ ๊ฐ„์žฅ์˜ ์ด์ƒ์ด ์ดˆ๋ž˜๋˜๋ฉฐ ๊ทธ ์ฃผ์š” ์งˆํ™˜์œผ๋กœ ์šฐ๋ฆฌ๋‚˜๋ผ์—์„œ๋Š” ๋‹น์›๋ณ‘, ์œŒ์Šจ๋ณ‘, ๊ณ ์„ธ๋ณ‘ ๋“ฑ์ด ๊ฐ€์žฅ ๋งŽ์Œ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋”ฐ๋ผ์„œ ์†Œ์•„์—์„œ ์›์ธ ๋ถˆ๋ช…์˜ ๊ฐ„์žฅ ๋ฐ ๋น„์žฅ ์ข…๋Œ€๋ฅผ ๋™๋ฐ˜ํ•˜๋ฉด์„œ ๊ฐ„๊ธฐ๋Šฅ ์ด์ƒ ์†Œ๊ฒฌ์ด ์žˆ์„ ๋•Œ ๊ฐ€๋Šฅํ•œ ๊ฐ„์ƒ๊ฒ€์„ ์‹œํ–‰ํ•จ์œผ๋กœ์จ ์กฐ๊ธฐ์— ์„ ์ฒœ์„ฑ ๋Œ€์‚ฌ์„ฑ ๊ฐ„์งˆํ™˜์„ ๋ฐœ๊ฒฌํ•  ์ˆ˜ ์žˆ์„ ๊ฒƒ์œผ๋กœ ์ƒ๊ฐ๋œ๋‹ค. [์˜๋ฌธ] The liver plays a central role in synthetic, degradative, and regulatory pathways involving the metabolism of carbohydrates, protein, lipid, mineral, and vitamins. There are many metabolic abnormalities or specific enzyme deficiencies that affect the liver. The clinical manifestations of metabolic diseases of the liver mimic infections, intoxications, and other systemic diseases. The comprehension of the pathogenesis on the inborn metabolic errors and early diagnosis are essential to a good prognosis. But there are few reports on this category of the diseases in Korea, probably because of relatively low incidence, low index of suspicion, and lack of confirmative diagnostic tools. This investigative study of the clinical, laboratory, and pathologic findings of the underlying conditions of the patients, who were admitted during the period from January 1980 to December 1990 with the metabolic diseases related to the hepatic dysfunction to the department of Pediatrics, Yonsei University College of Medicine. The results were as follows: 1. There were obvious liver disorders in 30 cases of 62 patients (48%) with the inborn errors of metabolism, including glycogen storage disease, wilson disease, Gaucher disease, hereditary tyrosinemia, histidinemia, phenylketonuria and mucopolysaccharidosis. 2. These metabolic problems were most common in the age group of 1 to 5 years old age group, and there was no statistical significance in sex ratio, except in Gaucher disdisease, where there was a female predominance(1:3). 3. The eldest group at diagnosis was those with Wilson disease and the longest duration between the onset of symptoms and the diagnosis was in cases of phenylketonuria. 4. More than 90% of the patients were of the full-term and of average gestational age. Only 6.7% of the patients were of low birth weights, but 70% and 56% were below the 50th percentile in weight and height, repectively, on admission. Therefore, there was growth retardation after birth. 5. Frequent clinical manifestations included hepatomegaly (53%), splenomegaly(43%), hepatosplenomegaly(40%), abdominal distension (40%) and growth retardation (30%). The major enlarged organs in GSD and Gaucher disease were the liver and the spleen. 6. Family histories were found in 47% of the patients, most frequent(30%) in siblings. 7. The laboratory findings were anemia(50%), elevated AST(100%), elevated ALT(60%) and elevated serum total bilirubin level(37%). 8. the pathologic findings on liver biopsy were hepatocyte swelling, glycogen nuclei, intrahepatic cholestasis and fatty changes. The above results indicate there were obvious liver disorders in about half of the patients with the inborn errors of metabolism, such as glycogen storage disease, Wilson disease, and Gaucher disease in Korea. Further evaluations of the liver, such as the liver biopsy, are essential to early diagnosis and good prognosis for the inborn errors of metabolism and should be required in the patients with the unknown hepatomegaly, splenomegaly, and deteriorated liver function.restrictio

    Factors associated with unmet needs of daily living assistance in the disabled elderly.

    No full text
    ๋ณด๊ฑด์ •์ฑ… ๋ฐ ๊ด€๋ฆฌํ•™๊ณผ/์„์‚ฌ[ํ•œ๊ธ€] ์ „ ์„ธ๊ณ„์ ์œผ๋กœ ๋…ธ์ธ์ธ๊ตฌ๊ฐ€ ๊ธ‰์†ํ•˜๊ฒŒ ์ฆ๊ฐ€ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์šฐ๋ฆฌ๋‚˜๋ผ์˜ ๊ฒฝ์šฐ๋„ ๊ณ ๋ น์‚ฌํšŒ์— ์ด๋ฅด๋Š” ์†๋„๊ฐ€ ๋น ๋ฅด๊ฒŒ ์ง„ํ–‰๋˜๊ณ  ์žˆ๋‹ค. ๋…ธ๋…„๊ธฐ๋Š” ์‹ ์ฒด์ , ์ •์‹ ์ ์œผ๋กœ ๊ธฐ๋Šฅ์ด ์ €ํ•˜๋˜๊ณ  ์งˆ๋ณ‘ ์ดํ™˜์œจ์ด ์ฆ๊ฐ€ํ•œ๋‹ค. ์‹ ์ฒด๊ธฐ๋Šฅ์žฅ์• ๋กœ ํ™œ๋™์ด ์–ด๋ ค์›Œ์ง€๋ฉด ๊ฐ€์กฑ ๋ถ€์–‘ ๋“ฑ ์ˆ˜๋ฐœ์„ ์š”๊ตฌํ•˜๊ฒŒ ๋˜๋Š”๋ฐ ํ˜„์žฌ ๊ทธ ์‹คํƒœํŒŒ์•…์ด ๋ถ€์กฑํ•œ ์‹ค์ •์ด๋‹ค. ๊ทธ๋Ÿฌ๋ฏ€๋กœ ์ด ์—ฐ๊ตฌ๋Š” ์ˆ˜์›์‹œ์— ๊ฑฐ์ฃผํ•˜๋Š” 65์„ธ ์ด์ƒ์˜ ์žฌ๊ฐ€๋…ธ์ธ 979๋ช…์„ ๋Œ€์ƒ์œผ๋กœ ์ผ์ƒ์ƒํ™œ ์ˆ˜ํ–‰๋Šฅ๋ ฅ(ADL)๊ณผ ์ˆ˜๋‹จ์  ์ผ์ƒ์ƒํ™œ ์ˆ˜ํ–‰๋Šฅ๋ ฅ(IADL)์˜ ์žฅ์•  ์‹คํƒœ๋ฅผ ์กฐ์‚ฌํ•˜์—ฌ, ์ˆ˜๋ฐœ ๋ฏธ์ถฉ์กฑ ์ˆ˜์š”๋ฅผ ํŒŒ์•…ํ•˜๊ณ  ์ผ๋ฐ˜์ ํŠน์„ฑ๊ณผ ๊ฑด๊ฐ•์ƒํƒœ, ์‚ฌํšŒ์  ์ง€์›, ์„œ๋น„์Šค ์ด์šฉ ๋“ฑ ์—ฌ๋Ÿฌ ์š”์ธ๋“ค๊ณผ ๊ด€๋ จ์ด ์žˆ๋Š”์ง€ ๊ทœ๋ช…ํ•˜๊ณ ์ž ํ•˜์˜€๋‹ค. ์‹ ์ฒด๊ธฐ๋Šฅ์˜ ์žฅ์•  ์‹คํƒœ๋Š”, ADL์—์„œ ์•‰์•˜๋‹ค ์ผ์–ด์„œ๊ธฐ(16.8%)์™€, IADL์˜ ๋Œ€์ค‘๊ตํ†ต์ˆ˜๋‹จ ์ด์šฉ(26.8%)์—์„œ ๊ฐ€์žฅ ๋†’์•˜์œผ๋ฉฐ, ๊ฐ๊ฐ์— 2๊ฐœ ์ด์ƒ์˜ ์žฅ์• ๋ฅผ ์ง€๋‹Œ ๋…ธ์ธ๋„ ๋ชจ๋‘ 55%์ด์ƒ์œผ๋กœ ๋†’๊ฒŒ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋ฏธ์ถฉ์กฑ ์ˆ˜์š”๋Š” ADL์— ๋ชฉ์š•ํ•˜๊ธฐ(35.6%)๊ฐ€ ๊ฐ€์žฅ ๋งŽ์•˜๊ณ , IADL์€ ๋ฌผ๊ฑด๊ตฌ์ž…(26.5%)๊ณผ ๋Œ€์ค‘๊ตํ†ต์ˆ˜๋‹จ ์ด์šฉ(26.4%)์ด ๋น„์Šทํ•œ๋ถ„ํฌ๋กœ ๋†’๊ฒŒ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋˜ํ•œ 1๊ฐœ ์ด์ƒ์˜ ๋ฏธ์ถฉ์กฑ ํ•ญ๋ชฉ์„ ์ง€๋‹Œ ๊ฒฝ์šฐ๋Š” ADL(33.7%)์ด IADL(29.4%)๋ณด๋‹ค ๋†’์Œ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ADL์˜ ๋ฏธ์ถฉ์กฑ๊ณผ ๊ด€๋ จ ์žˆ๋Š” ์š”์ธ์œผ๋กœ๋Š” ๊ต์œก์ˆ˜์ค€(p<.048)๊ณผ ๊ด€์ ˆ์—ผ(p<.017), ADL ์žฅ์•  ์ˆ˜(p<.012)๋กœ ๋ถ„์„๋˜์—ˆ๊ณ , IADL์€ ๊ด€์ ˆ์—ผ(p<.000), IADL์žฅ์•  ์ˆ˜(p<.046), ์ž…์›์—ฌ๋ถ€(p<.039)์ด์—ˆ๋‹ค. ๋ฏธ์ถฉ์กฑ๊ณผ ์ „์ฒด ์š”์ธ๊ณผ์˜ ๋‹ค๋ณ€๋Ÿ‰ ๋ถ„์„์—์„œ๋Š” ADL, IADL ๋ชจ๋‘ ์žฅ์•  ์ˆ˜์™€ ๊ด€์ ˆ์—ผ์ด ์œ ์˜ํ•˜์—ฌ, ๋Œ€๋ถ€๋ถ„์˜ ๋…ธ์ธ๋“ค์ด ์ผ์ƒ์ƒํ™œ์„ ์ˆ˜ํ–‰ํ•˜๋Š”๋ฐ ์žˆ์–ด ์žฅ์• ๊ฐ€ ๋งŽ์„์ˆ˜๋ก ์–ด๋ ค์›€์ด ๋งŽ๊ณ , ์ˆ˜๋ฐœ์— ๋Œ€ํ•œ ์š•๊ตฌ๋„ ์ปค์ง€๋Š” ๊ฒƒ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋˜ํ•œ ๋ณต์ง€๋ณด๋‹ค๋Š” ๋ณด๊ฑด ์ธก๋ฉด์— ๋ฏธ์ถฉ์กฑ ์ˆ˜์š”๊ฐ€ ๋งŽ์•„ ์ƒ๋Œ€์ ์œผ๋กœ ์ œ๊ณต์ด ๋ฏธํกํ•œ ๋ณด๊ฑด์˜๋ฃŒ์„œ๋น„์Šค์— ์š•๊ตฌ๊ฐ€ ํฐ ๊ฒƒ์œผ๋กœ ๋ณด์˜€๋‹ค. ๊ด€์ ˆ์—ผ์€ ์šฐ๋ฆฌ๋‚˜๋ผ ๋…ธ์ธ์—๊ฒŒ ๊ฐ€์žฅ ๋งŽ์ด ๋‚˜ํƒ€๋‚˜๋Š” ๋งŒ์„ฑ์งˆํ™˜๋ฟ ์•„๋‹ˆ๋ผ ์ˆ˜๋ฐœ ์š•๊ตฌ๋„ ๋†’์•˜๋‹ค. ํ•ญ๋ชฉ๋ณ„ ๋ถ„์„์—์„œ๋Š” ๊ด€์ ˆ์—ผ๊ณผ ์š”ํ†ต, ์ž…์›, ์žฅ์•  ์ˆ˜ ๋“ฑ ์—ฌ๋Ÿฌ ์š”์ธ๋“ค๊ณผ ๊ด€๋ จ์ด ์žˆ์—ˆ๊ณ , ํŠนํžˆ ์ž…์›์€ ๋ชฉ์š•ํ•˜๊ธฐ(p<.048), ์•‰์•˜๋‹ค ์ผ์–ด์„œ๊ธฐ(p<.037), ํ™”์žฅ์‹ค ์ด์šฉ(p<.009), ๋ฌผ๊ฑด๊ตฌ์ž…(p<.012)์—์„œ ๋ชจ๋‘ ๋ฏธ์ถฉ์กฑ ์ˆ˜์š”์™€ ๊ด€๋ จ ์žˆ๋Š” ์š”์ธ์œผ๋กœ ๋ถ„์„๋˜์—ˆ๋‹ค. ๋”ฐ๋ผ์„œ ๋…ธ์ธ์€ ์žฌ๊ฐ€๋ณดํ˜ธ ๋ฟ ์•„๋‹ˆ๋ผ ์‹œ์„ค๋ณดํ˜ธ์— ์žˆ์–ด์„œ๋„ ๋งŽ์€ ์š•๊ตฌ๋ฅผ ๊ฐ€์ง€๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ด์— ๋…ธ์ธ ์ˆ˜๋ฐœ ๋ฏธ์ถฉ์กฑ์— ๋Œ€ํ•œ ์—ฐ๊ตฌ๋Š” ์žฅ๊ธฐ์š”์–‘์„œ๋น„์Šค์˜ ์ž ์žฌ ์ˆ˜์š”๋ฅผ ์˜ˆ์ƒํ•  ์ˆ˜ ์žˆ๋‹ค๋Š” ์ ์—์„œ ์ข‹์€ ๊ทผ๊ฑฐ ์ž๋ฃŒ๊ฐ€ ๋  ๊ฒƒ์ด๋‹ค. ํ–ฅํ›„ ๋…ธ์ธ์˜ ๊ธฐ๋Šฅ์ƒํƒœ ๋ณ€ํ™”๋‚˜ ์ˆ˜๋ฐœ ์ˆ˜์š”์˜ ์žฅ๊ธฐ ์ถ”์  ์กฐ์‚ฌ๋Š” ์ „์ฒด ์ง€์—ญ์‚ฌํšŒ๋กœ ํ™•๋Œ€ ์‹ค์‹œ๋˜์–ด์ ธ์•ผ ํ•˜๋ฉฐ, ๋…ธ์ธ ์‚ถ์˜ ์งˆ ํ–ฅ์ƒ์„ ์œ„ํ•ด ๊ตญ๊ฐ€๊ฐ€ ๋’ท๋ฐ›์นจํ•˜๋Š” ์‹œ์ฑ…์œผ๋กœ ๊ฑฐ๋“ญ๋‚˜์•ผ ํ•  ๊ฒƒ์ด๋‹ค. [์˜๋ฌธ] The population of the elderly is increasing rapidly throughout the world and also in Korea. Physical and mental functions decrease and the disease rate increases in older people. Once daily living gets difficult in the elderly due to decreased physical functions, the elderly require assistance from people such as from their families. However, data are currently lacking on the factors associated with daily living assistance. Thus, we investigated the status related with ADL(activities of daily living) and IADL (instrumental activities of daily living) in 979 community dwelling older people older than 65 years of ge residing in Suwon city in order to determine the unmet needs of assistance and relationship with several factors such as general characteristics, health status, social support and service utilization. The most prevalent handicap associated with physical functions was transferring(16.8%) in ADL and was using public transportation(26.8%) in IADL. The rate of having more than 2 handicaps was high at 55%. The most prevalent unmet needs were bathing(35.6%) in ADL, and buying products(26.5%) and using public transportation(26.4%) in IADL. A higher rate of more than one unmet need was present in ADL(33.7%) compared with IADL(29.4%). The factors associated with unmet need in ADL were education level(p<.048), arthritis(p<.017), and the number of ADL handicaps(p<.012). The factors associated with unmet need in IADL were arthritis(p<.000), the number of IADL handicaps(p<.046), and hospitalization(p<.039). Multiple analysis of variance of unmet needs showed a significant relationship with the number of handicaps and arthritis in both ADL and IADL, suggesting that the elderly experience more difficulty and require more assistance with more number of handicaps. Furthermore, more need was present from the health sector rather than the welfare sector, showing more need for health and welfare services, which are lagging in Korea. Arthritis is a chronic disease most prevalent in the Korean elderly and required a high rate of assistance. According to each item, arthritis, back pain, hospitalization and number of handicaps were associated with unmet needs. Hospitalization especially was the factor related with all unmet needs such as bathing(p<.048),transferring(p<.037), using toilet(p<.009), buying products(p<.012). Therefore, the elderly had many needs requiring both community and institutional care. Studies on unmet needs for assisting the elderly would provide good data for predicting the potential need for long care services. Long-terms studies on functional changes or the need for assistance should be conducted in different regions and the results of these studies should be reflected in national policies for improving the quality of life in the elderly.ope

    ๊ธ€๋กœ๋ฒŒ ์ธํ„ฐ๋„ท ๋ ˆ์ง์—์„œ ๅœ‹ๅฎถ ๅ”ๅŠ›์˜ ้™็•Œ : ICANN๊ณผ WSIS ไบ‹ไพ‹๋ฅผ ไธญๅฟƒ์œผ๋กœ

    No full text
    Thesis(master`s)--์„œ์šธ๋Œ€ํ•™๊ต ๊ตญ์ œ๋Œ€ํ•™์› :๊ตญ์ œํ•™๊ณผ(๊ตญ์ œํ˜‘๋ ฅ์ „๊ณต),2007.Maste
    corecore